Rabies vaccine - LakeShore Biopharma
Alternative Names: PIKA adjuvant-based rabies vaccine - LakeShore Biopharma; PIKA rabies vaccine - LakeShore BiopharmaLatest Information Update: 22 Aug 2024
At a glance
- Originator Yisheng Biopharma
- Developer Duke-NUS Graduate Medical School Singapore; LakeShore Biopharma
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Rabies